The redox state as a correlate of senescence and wasting and as a target for therapeutic intervention

Blood

Volumn 92, Issue 1, 1998, Pages 59-67

  Hack, Volker ^b   Breitkreutz, Raoul ^b   Kinscherf, Ralf ^b   Röhrer, Helmut ^b   Bärtsch, Peter ^b   Taut, Friedemann ^b   Benner, Axel ^b   Dröge, Wulf ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALBUMIN; AMINO ACID; ANTIOXIDANT; CYSTINE; GLUTAMIC ACID; GLUTAMINE; GLUTATHIONE; INTERLEUKIN 2; THIOL; WATER;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; ORAL DRUG ADMINISTRATION; OXIDATION REDUCTION STATE; PHOTOMETRY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENESCENCE; SUBCUTANEOUS DRUG ADMINISTRATION; WASTING SYNDROME;

EID: 0032125750     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.1.59.413a05_59_67     Document Type: Article

References (59)

1. Cohn SH, Vartsky D, Yasumura S, Sawitsky A, Zanzi I, Vaswani A, Ellis KJ: Compartmental body composition based on total-body nitrogen, potassium, and calcium. Am J Physiol 239;E524, 1980
2. Brennan MF: Uncomplicated starvation versus cancer cachexia. Cancer Res 37:2359, 1977
3. DeWys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass Ho Jr, Engstrom PF, Ezdinli EZ, Horton J, Johnson GJ, Moertel CG, Oken MM, Perlia C, Rosenbaum C, Silverstein MN, Skeel RT, Sponzo RW. Tormey DC: Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 69:491, 1980
4. Strain AJ: Cancer cachexia in man. A review. Invest Cell Pathol 2:181, 1979
5. Pisters PW, Pearlstone DB: Protein and amino acid metabolism in cancer cachexia: Investigative techniques and therapeutic interventions. Crit Rev Clin Lab Sci 30:223, 1993
6. Long CL, Crosby F, Geiger JW, Kinney JM: Parenteral nutrition in the septic patient: Nitrogen balance, limiting plasma amino acids, and calorie to nitrogen ratios. Am J Clin Nutr 29:380, 1976
7. Ott M, Lembcke B, Fischer H, Jager R, Polat H, Geier H, Rech M, Staszeswki S, Helm EB, Caspary WF: Early changes of body composition in human immunodeficiency virus-infected patients: Tetrapolar body impedance analysis indicates significant malnutrition. Am J Clin Nutr 57:15, 1993
8. Kotler DP, Wang J, Pierson R: Body composition in patients with the acquired immunodeficiency syndrome. Am J Clin Nutr 42:1255, 1985
9. Buchner DM, Wagner EH: Preventing frail health. Clin Geriatr Med 8:1, 1992
10. Rothschild MA, Oratz M, Schreiber SS: Serum albumin. Hepatology 8:385, 1988
11. Cooper JK, Gardner C: Effect of aging on serum albumin. J Am Geriatric Soc 37:1039, 1989
12. Shibata H. Haga H, Ueno M, Nagai H, Yasumura S, Koyano W: Longitudinal changes of serum albumin in elderly people living in the community. Age and Aging 20:417, 1991
13. Baumgartner RN, Koehler KM, Romero L, Garry PJ: Serum albumin is associated with skeletal muscle in elderly men and women. Am J Clin Nutr 64:552, 1996
14. Tayek JA: Albumin synthesis and nutritional assessment. Nutr Clin Pract 3:219, 1988
15. Naber THJ, de Bree A, Schermer TRJ, Bakkeren J, Bär B, de Wild G, Katan MB: Specificity of indexes of malnutrition when applied to apparently healthy people: The effect of age. Am J Clin Nutr 65:1721, 1997
16. Brody JA: Prospects for an aging population. Nature 315:463, 1985
17. Lamberts SWJ, van den Beld AW, van der Lely A-J: The endocrinology of aging. Science 278:419, 1997
18. Campion EW: The oldest old. N Engl J Med 330:1819, 1994
19. Fiatarone MA, O'Neill EF, Ryan ND, Clements KM, Solares GR, Nelson ME, Roberts SB, Kehayias JJ, Lipsitz LA, Evans WJ: Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med 330:1769, 1994
20. Harman D: Aging: A theory based on free radical and radiation chemistry. J Geronterol 11:298, 1956
21. Shigenaga MK, Hagen TM, Ames BN: Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci USA 91:10771, 1994
22. Stadtman ER: Protein oxidation and aging. Science 257:1220, 1992
23. Gilchrest BA, Bohr VA: Aging processes, DNA damage, and repair. FASEB J 11:322, 1997
24. Manton KG, Corder LS, Stallard E: Monitoring changes in the health of the U.S. elderly population: Correlates with biomedical research and clinical innovations. FASEB J 11:923, 1997
25. Tuten MB, Wogt S, Dasse F, Leider Z: Utilization of prealbumin as a nutritional parameter. J Parent Ent Nutr 9:709, 1985
26. Erstad BL: Serum albumin concentrations: Who needs them? Ann Pharmacother 26:1134, 1992
27. Paluzzi M, Meguid MM: A prospective randomized study of the optimal source of nonprotein calories in total parenteral nutrition. Surgery 102:711, 1987
28. Finch JW, Crouch RK, Knapp DR, Schey KL: Mass spectrometric identification of modifications to human serum albumin treated with hydrogen peroxide. Arch Biochem Biophys 305:595, 1993
29. Kuwata K, Era S, Sogami M: The kinetic studies on the intracellular SH, S-S exchange reaction of bovine mercaptalbumin. Biochim Biophys Acta 1205:317, 1994
30. Halliwell B, Gutteridge MC: The antioxidants of human extracellular fluids. Arch Biochem Biophys 280:1, 1990
31. Era S, Kuwata K, Imai H, Nakamura K, Hayashi T, Sogami M: Age-related change in redox state of human serum albumin. Biochim Biophys Acta 1247:12, 1995
32. Era S, Hamaguchi T, Sogami M, Kuwata K. Suzuki E, Miura K, Kawai K, Kitazawa Y, Okabe H, Noma A, Miyata S: Further studies on the resolution of human mercapt- and nonmercaptalbumin and on human serum albumin in the elderly by high-performance liquid chromatography. Int J Peptide Protein Res 31:435, 1988
33. Hack V, Stütz O. Kinscherf R. Schykowski M, Kellerer M, Holm E, Dröge W: Elevated venous glutamate levels in (pre)catabolic conditions result at least partly from a decreased glutamate transport activity. J Mol Med 74:337, 1996
34. Miles DW, Thomsen L, Balkwill F, Thavasu P, Moncada S: Association between biosynthesis of nitric oxide and changes in immunological and vascular parameters in patients treated with interleukin-2. Eur J Clin Invest 24:287, 1994
35. Dröge W, Groβ A, Hack V, Kinscherf R, Schykowski M, Bockstette M, Mihm S, Galter D: Role of cysteine and glutathione in HIV infection and cancer cachexia. Therapeutic intervention with N-acetyl-cysteine (NAC). Adv Pharmacol 38:581, 1997
36. Ottery FD: Supportive nutrition to prevent cachexia and improve quality of life. Semin Oncol 22:98, 1995 (suppl 3)
37. Kinscherf R, Hack V, Fischbach T, Friedmann B, Weiss C, Edler L, Bärtsch P, Dröge W: Low plasma glutamine in combination with high glutamate levels indicate risk for loss of body cell mass in healthy individuals: the effect of N-acetyl-cysteine. J Mol Med 74:393, 1996
38. Corcoran R, Duran S: Albumin determination by a modified bromcresol green method. Clin Chem 23:765, 1977
39. Pool MO, Bouma G, Visser JJ, Kolkman JJ, Tran DD, Meuwissen SGM, Pena AS: Serum nitrate levels in ulcerative colitis and Crohn's disease. Scand J Gastroenterol 30:784, 1995
40. Agresti A: Categorial Data Analysis. New York, NY, Wiley, 1990
41. Rothschild MA, Oratz M, Schreiber SS: Albumin synthesis. N Engl J Med 286:748, 1972
42. Tayek JA: A review of cancer cachexia and abnormal glucose metabolism in humans with cancer. J Am Col Nutr 11:445, 1992
43. Dimeo F, Fetscher S, Lange W, Mertelsmann R, Keul J: Effects of aerobic exercise on the physical performance and incidence of treatment-related complications after high-dose chemotherapy. Blood 90:3390, 1997
44. Sastre J, Asensi M, Gasco E, Pallardo FV, Ferrero JA, Furukawa T, Vina J: Exhaustive physical exercise causes oxidation of glutathione status in blood: Prevention by antioxidant administration. Am J Physiol 263:R992, 1992
45. Sen CK, Rankinen T, Väisänen S, Rauramaa R: Oxidative stress after human exercise: Effect of N-acetylcysteine supplementation. J Appl Physiol 76:2570, 1994
46. Lausen B, Schumacher M: Evaluating the effect of optimized cutoff values in the assessment of prognostic factors. Comp Stat Data Anal 21:307, 1996
47. Astrand I: Maximal oxigen uptake. Acta Physiol Scand 49:1, 1960 (suppl 169)
48. Cotgreave IA: N-acetylcysteine: Pharmacological considerations and experimental and clinical applications. Adv Pharmacol 38:205, 1997
49. Hu H, Sparrow D, Weiss S: Association of serum albumin with blood pressure in the normative aging study. Am J Epidemiol 136:1465, 1992
50. Grune T, Reinheckel T, Davies KJA: Degradation of oxidized proteins in mammalian cells. FASEB J 11:526, 1997
51. Thomas D, Ritz M-F, Malviya AN, Gaillard S: Intracellular acidification mediates the proliferative response of PC 12 cells induced by potassium ferricyanide and involves MAP kinase activation. Int J Cancer 68:547, 1996
52. Aidoo A, Lyn-Cook LE, Morris SM, Kodell RL, Casciano DA: Comparative study of intracellular glutathione content in rat lymphocyte cultures treated with 2-mercaptoethanol and interleukin-2. Cell Biol Toxicol 7:215, 1991
53. Burgunder JM, Varriale A, Lauterburg BH : Effect of N-acetylcysteine on plasma cysteine and glutathione following paracetamol administration. Eur J Clin Pharmacol 36:127, 1989
54. Witschi A, Junker E, Schranz C, Speck RF, Lauterburg BH: Supplementation of N-acetylcysteine fails to increase glutathione in lymphocytes and plasma of patients with AIDS. AIDS Res Human Retrovir 11:141, 1995
55. van Zandwijk N: N-acetylcysteine (NAC) and glutathione (GSH): Antioxidant and chemopreventive properties, with special reference to lung cancer. J Cell Biochem 22:24, 1995 (suppl)
56. Delneste Y, Jeannin P, Potier L, Romero P, Bonnefoy J-Y: N-acetyl-L-cysteine exhibits antitumoral activity by increasing tumor necrosis factor α-dependent T-cell cytotoxicity. Blood 90:1124, 1997
57. Dröge W: Metabolische Störungen bei HIV-Infektion, in: Project News, No. 2. Berlin, Germany, AIDS-Zentrum des Bundesgesundheitsamtes, 1989, p 4
58. Dröge W, Holm E: Role of cysteine and glutathione in HIV infection and other diseases associated with muscle wasting and immunological dysfunctions. FASEB J 11:1077, 1997
59. Nakamura H, De Rosa S, Roederer M, Anderson MT, Dubs JG, Yodoi J, Holmgren A, Herzenberg LA, Herzenberg LA: Elevation of plasma thioredoxin levels in HIV-infected individuals. Int Immunol 8:603, 1996